Erin Wilson

Stock Analyst at Morgan Stanley

(1.76)
# 3,340
Out of 5,044 analysts
23
Total ratings
46.15%
Success rate
0.75%
Average return

Stocks Rated by Erin Wilson

Rapid7
Sep 2, 2025
Maintains: Equal-Weight
Price Target: $28$22
Current: $18.93
Upside: +16.22%
Align Technology
Jul 29, 2021
Maintains: Outperform
Price Target: $715$732
Current: $133.14
Upside: +449.80%
Charles River Laboratories International
Jul 20, 2021
Maintains: Neutral
Price Target: $352$385
Current: $187.93
Upside: +104.86%
IQVIA Holdings
Jul 20, 2021
Maintains: Outperform
Price Target: $242$265
Current: $218.13
Upside: +21.49%
Medpace Holdings
Jul 20, 2021
Maintains: Outperform
Price Target: $200$205
Current: $580.53
Upside: -64.69%
ICON Public Limited Company
Jul 20, 2021
Maintains: Outperform
Price Target: $245$250
Current: $177.73
Upside: +40.66%
Elanco Animal Health
Feb 26, 2021
Upgrades: Outperform
Price Target: $33$38
Current: $22.12
Upside: +71.79%
Fulgent Genetics
Jan 8, 2021
Downgrades: Underperform
Price Target: n/a
Current: $23.43
Upside: -
Thermo Fisher Scientific
Jan 22, 2020
Initiates: Neutral
Price Target: $341
Current: $557.63
Upside: -38.85%
InterCure
Nov 14, 2017
Maintains: Outperform
Price Target: $68$54
Current: $1.44
Upside: +3,650.00%